Who should be prioritized for COVID-19 vaccination in China? A descriptive study

BACKGROUND: All countries are facing decisions about which population groups to prioritize for access to COVID-19 vaccination after the first vaccine products have been licensed, at which time supply shortages are inevitable. Our objective is to define the key target populations, their size, and pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Juan, Zheng, Wen, Shi, Huilin, Yan, Xuemei, Dong, Kaige, You, Qian, Zhong, Guangjie, Gong, Hui, Chen, Zhiyuan, Jit, Mark, Viboud, Cecile, Ajelli, Marco, Yu, Hongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872877/
https://www.ncbi.nlm.nih.gov/pubmed/33563270
http://dx.doi.org/10.1186/s12916-021-01923-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872877/
https://www.ncbi.nlm.nih.gov/pubmed/33563270
http://dx.doi.org/10.1186/s12916-021-01923-8

Ejemplares similares